Related Experiment Videos

Response to Sharawat and Suther

Michael R Pranzatelli¹, Elizabeth D Tate¹

¹National Pediatric Myoclonus Center, National Pediatric Neuroinflammation Organization, Inc, Orlando, Florida.

Pediatric Neurology

|November 25, 2017

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies.

Child neurology open·2018

Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.

Pediatric neurology·2018

Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.

Pediatric blood & cancer·2018

Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS.

Journal of neuroimmunology·2018

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Frontiers in immunology·2018

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2018

See all related articles